Electromedical Technologies'
New Weekly Marketing Series Launches This
Week
- Electromedical successfully launched its
first practitioner testimonial event last
week
- Wednesday Facebook Live
events feature doctor and
patients championing WellnessPro
Plus® benefits
- Thursday Online Facetime meetings
include new distributor on-boarding and
training
SCOTTSDALE, AZ -- May 25,
2021 -- InvestorsHub NewsWire -- Electromedical Technologies,
Inc. (OTCQB:
EMED)
(the "Company"), a pioneer in the development and manufacturing of
bioelectronic devices, including the FDA cleared
WellnessPro Plus®, is pleased to announce
that following a successful
Facebook
Live WellnessPro Plus®
testimonial
event
with a noted
chiropractor, the Company is launching two weekly marketing events,
beginning Wednesday, May 26, 2021. EMED Sales Director Kathy
Strand R.N leads the marketing event
series with practitioners, thought
leaders, patients, and EMED executives as part of the Company's
strategic
plan to
foster broad product
awareness
and
utilization, increase sales, and
on-board new EMED
distributors.
Each Wednesday, Electromedical
Technologies will host Facebook Live events featuring doctors and
patients sharing their respective successful experiences when using
EMED's WellnessPro Plus®
bioelectronic device to treat chronic
pain (https://www.facebook.com/electromedtech).
Thursday events
include new distributor on-boarding and training as
a critical tool
to
on-board 200
active distributors by year-end
2021.
Matthew Wolfson, Founder and
CEO of Electromedical Technologies, noted, "We are pleased
our initial
Facebook Live event was a success and are excited to keep the momentum going
with two weekly online social media-driven webinars. Enabling
clinicians and patients to directly discuss their experiences and
benefits when using the WellnessPro Plus
® device
each week is a key method to teach participants
how the device
has helped change users' lives. Plus, the weekly training sessions
should serve as an opportunity to on-board and educate new
distributors, thereby potentially driving increased sales.
For questions on
how to become a Wellness pro distributor contact our office
at questions@electromedtech.com "
About
Electromedical Technologies
Headquartered in
Scottsdale, Arizona, Electromedical
Technologies, Inc. is a commercial stage, FDA cleared,
bioelectronic medical device manufacturing company initially
focused on the treatment of various chronic, acute, intractable,
and post-operative pain conditions. Through University collaboration
agreements, the Company is working to develop
a comprehensive research program in defining the
effects of
electro-modulation on the human body. By studying the impacts of
electrical fields in cell signaling and effects on virus assembly
and immune responses, the Company's goal is
to reduce
pain and improve overall human wellbeing. The
Company's current
FDA
cleared product
indications are for chronic acute post traumatic and
post-operative, intractable pain relief. For more information,
please
visit
www.electromedtech.com.
Safe Harbor
Statement
This release
contains forward-looking statements that are based upon current
expectations or beliefs, as well as a number of assumptions about
future events. Although we believe that the expectations reflected
in the forward-looking statements and the assumptions upon which
they are based are reasonable, we can give no assurance or
guarantee that such expectations and assumptions will prove to have
been correct. Forward-looking statements are generally identifiable
by the use of words like "may," "will," "should," "could,"
"expect," "anticipate," "estimate," "believe," "intend," or
"project" or the negative of these words or other variations on
these words or comparable terminology. The reader is cautioned not
to put undue reliance on these forward-looking statements, as these
statements are subject to numerous factors and uncertainties,
including but not limited to: adverse economic conditions,
competition, adverse federal, state and local government
regulation, international governmental regulation, inadequate
capital, inability to carry out research, development and
commercialization plans, loss or retirement of key executives and
other specific risks. To the extent that statements in this press
release are not strictly historical, including statements as to
revenue projections, business strategy, outlook, objectives, future
milestones, plans, intentions, goals, future financial conditions,
events conditioned on stockholder or other approval, or otherwise
as to future events, such statements are forward-looking, and are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. The forward-looking
statements contained in this release are subject to certain risks
and uncertainties that could cause actual results to differ
materially from the statements made.
Corporate
Contact:
Electromedical Technologies,
Inc.
Hanover
International
Tel:
1.888.880.7888
email:
ir@electromedtech.com
https://electromedtech.com